| Product Code: ETC4759250 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Vaccines Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Vaccines Market - Industry Life Cycle |
3.4 Taiwan Vaccines Market - Porter's Five Forces |
3.5 Taiwan Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Taiwan Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Taiwan Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Taiwan Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Taiwan Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Taiwan Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and focus on preventive healthcare measures in Taiwan. |
4.2.2 Government initiatives to promote vaccination programs and campaigns. |
4.2.3 Rising prevalence of infectious diseases and outbreaks driving the demand for vaccines in Taiwan. |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes and approval requirements for new vaccines in Taiwan. |
4.3.2 Limited access to vaccines in remote or underserved areas of Taiwan. |
4.3.3 Vaccine hesitancy and misinformation leading to lower vaccination rates in certain demographics. |
5 Taiwan Vaccines Market Trends |
6 Taiwan Vaccines Market Segmentations |
6.1 Taiwan Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Vaccines Market Revenues & Volume, By Conjugate vaccines, 2021-2031F |
6.1.3 Taiwan Vaccines Market Revenues & Volume, By Inactivated and subunit vaccines, 2021-2031F |
6.1.4 Taiwan Vaccines Market Revenues & Volume, By Live attenuated vaccines, 2021-2031F |
6.1.5 Taiwan Vaccines Market Revenues & Volume, By Recombinant vaccines, 2021-2031F |
6.1.6 Taiwan Vaccines Market Revenues & Volume, By Toxoid vaccines, 2021-2031F |
6.2 Taiwan Vaccines Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Vaccines Market Revenues & Volume, By Monovalent vaccines, 2021-2031F |
6.2.3 Taiwan Vaccines Market Revenues & Volume, By Multivalent vaccines, 2021-2031F |
6.3 Taiwan Vaccines Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Vaccines Market Revenues & Volume, By Pneumococcal disease, 2021-2031F |
6.3.3 Taiwan Vaccines Market Revenues & Volume, By DTP, 2021-2031F |
6.3.4 Taiwan Vaccines Market Revenues & Volume, By Influenza, 2021-2031F |
6.3.5 Taiwan Vaccines Market Revenues & Volume, By HPV, 2021-2031F |
6.3.6 Taiwan Vaccines Market Revenues & Volume, By Meningococcal disease, 2021-2031F |
6.3.7 Taiwan Vaccines Market Revenues & Volume, By Polio, 2021-2031F |
6.3.8 Taiwan Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.3.9 Taiwan Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.4 Taiwan Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Vaccines Market Revenues & Volume, By Intramuscular and subcutaneous administration, 2021-2031F |
6.4.3 Taiwan Vaccines Market Revenues & Volume, By Oral administration, 2021-2031F |
6.4.4 Taiwan Vaccines Market Revenues & Volume, By Other routes of administration, 2021-2031F |
6.5 Taiwan Vaccines Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Vaccines Market Revenues & Volume, By Pediatric patients, 2021-2031F |
6.5.3 Taiwan Vaccines Market Revenues & Volume, By Adult patients, 2021-2031F |
7 Taiwan Vaccines Market Import-Export Trade Statistics |
7.1 Taiwan Vaccines Market Export to Major Countries |
7.2 Taiwan Vaccines Market Imports from Major Countries |
8 Taiwan Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates for key target populations in Taiwan. |
8.2 Number of vaccinations administered annually in Taiwan. |
8.3 Percentage increase in funding allocated to vaccination programs by the government. |
8.4 Rate of adoption of new vaccines in Taiwan. |
8.5 Number of reported cases of vaccine-preventable diseases in Taiwan. |
9 Taiwan Vaccines Market - Opportunity Assessment |
9.1 Taiwan Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Taiwan Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Taiwan Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Taiwan Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Taiwan Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 Taiwan Vaccines Market - Competitive Landscape |
10.1 Taiwan Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here